Microfluidics (bio), drug delivery, and point-of-care
Microfluidics and small point-of-care systems are set to revolutionise the future of health. They appear in prevention, diagnostics and monitoring processes. Additionally, these systems can provide benefit to drug delivery processes. CASLEO is dedicated to developing new systems that would positively impact and improve people’s health and well-being. The microfluidics and point-of-care systems of interest have incorporated liquid metal-based elements. Besides, CASLEO has a significant focus on developing different drugs that can impact pro-inflammatory conditions, neurotransmitters such as NO and H2S are being explored. Post transition metals can modulate the production of these neurotransmitter agents. Additionally, CASLEO is also interested in investigating the impact of transition and post transition metals and their compounds on single cells.
Proc. Natl. Acad. Sci. 111, 3304-3309 (2014). Liquid metal enabled pump. DOI: doi.org/10.1073/pnas.1319878111
Small 2020, 16, 1906744. Zinc Oxide Particles Catalytically Generate Nitric Oxide from Endogenous and Exogenous Prodrugs. DOI: 10.1002/smll.201906744
Nature Communications 2019, 10. Counting growth factors in single cells with infrared quantum dots to measure discrete stimulation distributions. DOI: 10.1038/s41467-019-08754-5